Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why MoonLake Immunotherapeutics Stock Shot Up 41.1% on Tuesday

TheMotleyFool

0 0

Why MoonLake Immunotherapeutics Stock Shot Up 41.1% on Tuesday: https://g.foolcdn.com/editorial/images/682728/gettyimages-1209892070.jpg

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company that specializes in therapies for inflammatory skin and joint diseases, saw its shares jump 41.1% on Tuesday.

The stock closed at $6.38 on Friday, then opened at $7.55 on Tuesday after the Memorial Day weekend, before rising to a high of $9 just after the opening bell. The stock has a 52-week high of $15.19 and a low of $4.25, and is down more than 25% this year.

Image source: Getty Images.

Source Fool.com

Like: 0

49fd5168-8e7d-4cf9-977e-25df3ea85234

Share